ALPA vs MANGALAM: Stock Comparison

ALPA LABORATORIES vs MANGALAM DRUG & CHEMUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

ALPA LABORATORIES is the larger company by market capitalisation. ALPA LABORATORIES shows a higher ROE, lower leverage and a higher ROCE, while MANGALAM DRUG & CHEM shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALPA leads 6; MANGALAM leads 2 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALPAMANGALAM

Valuation lens

What price are you paying?

Market CapContext only
₹133 Cr
₹48 Cr
P/E RatioSame reading
12.09x
P/B RatioSame reading
0.77x
EPSALPA has the higher reading
₹0.47
₹-4.83
Book ValueContext only
₹88.53
₹65.11
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ALPA is the larger company
₹133 Cr vs ₹48 Cr
EPS
ALPA has higher earnings per share
₹0.47 vs ₹-4.83
Revenue Growth (TTM YoY)
MANGALAM has faster revenue growth
-7.5% vs -21.4%
Qtr Profit Growth
MANGALAM has stronger quarterly profit growth
-1.13% vs -5.6%
ROE
ALPA has a higher ROE
7.58% vs -42.41%
ROCE
ALPA has a higher ROCE
7.63% vs -15.52%
Net Margin
ALPA has a higher net margin
14.33% vs -19.13%
Operating Margin
ALPA has a higher operating margin
15.19% vs -13.66%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALPAMANGALAM
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALPAMANGALAM
Live Price₹62.71₹30.02
Day Change-0.93%-0.92%
Volume9,19418,726
52-Week High₹99₹79.7
52-Week Low₹46.1₹22.8
Distance from 52W High-36.66%-62.33%

Valuation

MetricALPAMANGALAM
Market Cap₹133 Cr₹48 Cr
P/E Ratio12.09x
P/B Ratio0.77x
EPS₹0.47₹-4.83
Book Value₹88.53₹65.11
Dividend Yield0%0%

Growth

MetricALPAMANGALAM
Revenue Growth (TTM YoY)-21.4%-7.5%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth-5.6%-1.13%

Profitability & Leverage

MetricALPAMANGALAM
ROE7.58%-42.41%
ROCE7.63%-15.52%
Net Margin14.33%-19.13%
Operating Margin15.19%-13.66%
Debt to Equity0.01x0.99x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALPAMANGALAM
Promoter Holding57.19%35.65%
FII Holding0.35% 0.03 pp0.11% 0.21 pp
DII Holding0.07% 0.07 pp0%
Public Holding42.39% 0.04 pp64.24% 0.22 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALPA LABORATORIES and MANGALAM DRUG & CHEM.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.